Skip to main content
. 2013 Feb 5;8(2):e55311. doi: 10.1371/journal.pone.0055311

Figure 4. Characterization of the dose-response and time course of septic plasma treatment on trans-PMVEC EB-albumin leak.

Figure 4

(A) PMVEC on the apical aspect of inserts were cultured for 8-hours with varying concentrations of plasma isolated from 3 different patients with sepsis, and trans-PMVEC EB-albumin leak measured over the final 1-hour. (B) PMVEC on the apical aspect of inserts were treated with 20% plasma from 3 different septic patients for a total of 2-, 4-, or 8-hours, and trans-PMVEC EB-albumin leak measured over the final 1-hour. P<0.05 by ANOVA for both A and B; *: P<0.05 and **: P<0.01 vs FBS control.